{
    "nctId": "NCT03069313",
    "briefTitle": "Vitamin B12 for Aromatase Inhibitors Musculoskeletal Symptoms",
    "officialTitle": "A Single Arm Phase II Study of Oral Vitamin B12 for the Treatment of Aromatase Inhibitors (AI) Associated Musculoskeletal Symptoms in Women With Early Stage Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Relief of Joint Pain",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 41,
    "primaryOutcomeMeasure": "Percentage Change in Average Joint Pain in Women With Aromatase Inhibitor-associated Musculoskeletal Symptoms (AIMSS) Compared to Baseline as Measured by the Brief Pain Inventory Short Form (BPI-SF).",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Sign informed consent and Pain level \\> 4 in the BPI scale,\n* Stage I-III\n\nExclusion Criteria:\n\n* \\<18 yrs\n* Stage IV\n* BPI Score \\<4\n* Zubrod score \\>2",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}